Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).
Autor: | van Teeffelen, Augustinus S. P.1 stijn.van.teeffelen@mumc.nl, van der Ham, David P.2, Willekes, Christine1, Nasiry, Salwan Al1, Nijhuis, Jan G.1, van Kuijk, Sander3, Schuyt, Ewoud4,5, Mulder, Twan L. M.6, Franssen, Maureen T. M.7, Oepkes, Dick8, Jansen, Fenna A. R.8, Woiski, Mallory D.9, Bekker, Mireille N.9, Bax, Caroline J.10, Porath, Martina M.11, de Laat, Monique W. M.4, Mol, Ben W.4,12, Pajkrt, Eva4 |
---|---|
Zdroj: | BMC Pregnancy & Childbirth. 2014, Vol. 14 Issue 1, p1-6. 6p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |